Cancer Treatment Reviews
Volume 28, Issue 6 , Pages 321-333, December 2002

Management of the menopause in cancer survivors

  • Mark Clemons

      Affiliations

    • Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, Ont., Canada M4N 3M5
    • Corresponding Author InformationCorrespondence to: Mark Clemons, Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, Ont., Canada M4N 3M5. Tel.: +416-480-5847; Fax: +416-217-1338
  • ,
  • Andrew Clamp

      Affiliations

    • Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK
  • ,
  • Beverley Anderson

      Affiliations

    • Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK

Abstract 

The consequences of premature menopause are of great importance to cancer survivors. Oestrogen replacement therapy (with and without added progestins) is the most extensively researched agent for the treatment and prevention of menopausal problems. While this may be appropriate for symptom control in patients with tumours that are not hormone responsive, patients with hormone dependent tumours will require safe and effective alternative treatments for menopausal symptoms. This paper will discuss both the short-term and long-term consequences of the menopause in cancer survivors and will also offer various management strategies.

Keywords:  Menopause, cancer treatment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(02)00089-0

Cancer Treatment Reviews
Volume 28, Issue 6 , Pages 321-333, December 2002